Latest 8-K filings

NYSE
Cheniere Energy announced a quarterly cash dividend of $0.555 per common share, payable on August 18, 2026.
NASDAQ
Relmada Therapeutics announced the appointment of Bipin Dalmia, PhD, MBA, as Chief Business Officer to lead corporate strategy and business development.
NASDAQ
Bicara Therapeutics announces the appointment of Jeremy Bender, Ph.D., and Christy Oliger to its Board of Directors, enhancing its strategic and commercial expertise.
NASDAQ
Itron announced its second quarter 2026 financial results, reporting revenue of $563 million, a 7% decrease year-over-year, but highlighted record gross margin and earnings exceeding expectations, leading to an increased full-year earnings outlook.
NASDAQ
SolarMax Technology, Inc. has approved a 1-for-12 reverse stock split and a significant reduction in authorized shares.
NASDAQ
Standard BioTools Inc. announced the sale of its Mass Cytometry business to Multiplex Bio for up to $10 million and a $30 million buyout of contingent payments from Illumina, facilitating its merger with Treeline Biosciences.
NYSE
Universal Health Services, Inc. announced its second quarter 2026 financial results, reporting increased net income and revenues, and provided a revised full-year operating forecast.
NASDAQ
ASP Isotopes Inc. will host a Capital Markets Day in London on September 8, 2026, to provide updates on strategic direction and commercial momentum.
NYSE
Dynex Capital, Inc. has amended its distribution agreement to increase the number of common shares available for at-the-market offerings.
NYSE
Valmont Industries announces the upcoming retirement of Board Chair Mogens C. Bay, with Catherine J. Paglia set to succeed him.
NASDAQ
Camden National Corporation announced record net income of $23.0 million and diluted EPS of $1.35 for the second quarter of 2026, driven by strong revenue performance and loan growth.
NASDAQ
Turn Therapeutics Inc. provided an investor presentation detailing advancements in its GX-03 drug candidate for inflammatory diseases, including upcoming clinical trial milestones and market potential.
NYSE
CTS Corporation's July 2026 investor presentation outlines a strategy focused on diversified end markets, technological innovation, and strategic M&A to achieve a 10% CAGR.
NASDAQ
PACCAR Inc announced a 24% increase in net income for the second quarter of 2026, driven by higher revenues and increased truck deliveries.
NYSE
Hubbell Incorporated announced robust second quarter 2026 financial results, exceeding expectations with double-digit growth in sales and earnings, prompting an upward revision of its full-year guidance.
NASDAQ
Mid Penn Bancorp, Inc. released an investor presentation detailing its financial performance and strategic initiatives as of June 30, 2026.
NYSE
Ecolab Inc. announced second-quarter results with accelerated sales growth and double-digit EPS growth, leading to an upward revision of its full-year 2026 adjusted diluted EPS outlook.
NASDAQ
Edible Garden AG Incorporated has received an extension until August 15, 2026, to regain compliance with Nasdaq's minimum $1 bid price rule.
NASDAQ
KIDZ AI Inc. announced an increase in its share repurchase program by 50%, from $2 million to up to $3 million, signaling confidence in its long-term growth.
OQX
Vaxart, Inc. announced a reorganization of its Board of Directors' Nominating and Governance and Compensation Committees, with new chairs appointed effective August 1, 2026.
NASDAQ
WhiteHorse Finance, Inc. announced it will release its second quarter 2026 financial results on August 11, 2026, followed by a conference call.
NYSE
CTS Corporation announced robust second quarter 2026 financial results, driven by strong diversification momentum, leading to record margins and an increased full-year outlook.
NASDAQ
Franklin Electric announced robust second quarter 2026 financial results, exceeding prior year performance and leading to an upward revision of full-year revenue and EPS guidance.
OQX
Skyline Bankshares, Inc. announced robust second quarter 2026 financial results, showcasing record net income and significant year-over-year growth in key metrics.
NYSE
Oshkosh Corporation announced its second quarter 2026 financial results, reporting a decrease in net income and earnings per share compared to the prior year, while updating its full-year earnings per share outlook.
SunPower Inc. announced preliminary Q226 financial results showing a revenue decline and operating loss, but forecasts a significant improvement in Q326 with increased revenue and reduced losses, driven by cost-cutting and operational improvements.
NASDAQ
Commvault announced robust first quarter fiscal year 2027 financial results, highlighted by a 16% year-over-year increase in subscription revenue to a record $267 million and a 71% surge in free cash flow.
AMEX
InfuSystem Holdings, Inc. announced it will release its second quarter 2026 financial results on August 4, 2026, and will host an investor conference call.
XPLR Infrastructure, LP announced solid second-quarter 2026 financial results, including $38 million in net income and $523 million in adjusted EBITDA, while also completing a $150 million minimum buyout and fully repaying $500 million in convertible notes.
NASDAQ
Kiniksa Pharmaceuticals announced robust second quarter 2026 financial results, driven by significant growth in ARCALYST net product revenue and positive clinical trial updates for KPL-387.